Entera Bio Ltd. (ENTX)

Entera Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 23, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	94	78	17	21	81	20
Market Cap Growth	351.66%	351.66%	-17.80%	-74.05%	308.59%	-23.76%
Enterprise Value	86	71	10	7	54	13
Last Close Price	2.07	2.12	0.60	0.73	2.81	1.08
PS Ratio	519.45	431.41	-	156.95	141.91	54.33
PB Ratio	9.95	9.66	1.67	1.79	3.59	2.64
P/TBV Ratio	11.64	9.66	1.67	1.79	3.59	2.64
EV/Sales Ratio	473.11	394.91	-	51.05	94.51	35.56
Debt / Equity Ratio	0.03	0.03	0.04	0.01	0.01	0.06
Asset Turnover	0.02	0.02	-	0.01	0.03	0.03
Quick Ratio	7.47	7.47	10.10	9.36	7.93	4.81
Current Ratio	7.63	7.63	10.32	9.58	8.01	4.95
Return on Equity (ROE)	-103.34%	-103.34%	-80.30%	-76.17%	-81.04%	-115.46%
Return on Assets (ROA)	-56.64%	-56.64%	-44.65%	-43.06%	-42.77%	-52.83%
Return on Capital (ROIC)	-62.64%	-62.64%	-49.13%	-48.52%	-49.57%	-69.25%
Earnings Yield	-10.15%	-12.22%	-51.42%	-62.15%	-15.04%	-56.56%
FCF Yield	-7.25%	-8.73%	-42.38%	-59.65%	-11.21%	-53.50%
Buyback Yield / Dilution	-29.79%	-29.79%	-0.69%	-10.23%	-41.90%	-51.62%

Updated Nov 8, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q